Portfolio company
Dinamo Biotechnologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Dinamo Biotechnologies develops a precision immunology platform using DNA methylation and artificial intelligence to identify patient subpopulations for pharmaceutical partners developing targeted drugs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ditto Biosciences
The company develops parasite-derived protein therapies for pharmaceutical and biotechnology partners to treat patients with autoimmune diseases using an artificial intelligence platform.
Immunai
Immunai develops an immune system mapping platform for biopharmaceutical companies to discover and optimise drug targets and clinical trials.
Epana Bio
This company develops precision T-cell engagers and biologics using artificial intelligence and genomics to treat patients with autoimmune diseases.
Asylia Diagnostics
This company develops an artificial intelligence platform to identify biomarkers and drug targets for precision immunotherapy for pharmaceutical and diagnostic firms.
Epana
The company develops precision immune cell therapies and diagnostic atlases using genomics and artificial intelligence for patients with autoimmune diseases.
Deepflare
Deepflare provides an artificial intelligence platform to predict T-cell immunogenicity for biotechnology and pharmaceutical companies developing vaccines and cancer immunotherapies.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
Celsius Therapeutics
The company develops precision medicines for patients with autoimmune diseases and cancer by using single-cell genomic sequencing and machine learning to identify drug targets.